This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Aileron Therapeutics, Inc.. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: **Innovative Contributions of Karen Olson in Peptidomimetic Macrocycles**
Introduction
Karen Olson is an esteemed inventor based in Waltham, Massachusetts, with a notable portfolio of three patents that showcase her dedication to advancing medical science. Her latest work in the field of peptidomimetic macrocycles reflects her innovative spirit and commitment to improving treatments for various conditions, including cancer.
Latest Patents
One of Olson's most significant patents, titled "Peptidomimetic Macrocycles and Uses Thereof," describes the synthesis of these macrocycles and their application in treating conditions such as cancer. This patent highlights methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically active agent. Another important aspect of her work focuses on methods for treating solid tumors that lack a p53 deactivation mutation, underlining the potential of these macrocycles in targeted cancer therapies.
Career Highlights
Olson is currently affiliated with Aileron Therapeutics, Inc., a company known for its dedication to pioneering therapeutic solutions. Her role at Aileron has allowed her to leverage her expertise in peptide chemistry to develop new drug candidates that can potentially revolutionize treatment protocols for cancer and other serious conditions.
Collaborations
Throughout her career, Olson has collaborated with respected colleagues such as David Allen Annis and Manuel Aivado. These partnerships have been instrumental in the successful development of her innovative therapies, enriching the research environment and driving advancements in the field of medicinal chemistry.
Conclusion
Karen Olson's contributions to the scientific community through her innovative patents in peptidomimetic macrocycles position her as a significant figure in modern medicine. Her ongoing efforts at Aileron Therapeutics underscore the vital role that inventors like her play in the quest for more effective treatments and the advancement of healthcare solutions. As research continues to evolve, Olson's work will undoubtedly inspire future innovations and discoveries in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile